⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BPI Labs, LLC and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
BPI Labs, LLC
↗Largo, USA
BPI Labs is a specialized pharmaceutical manufacturer and FDA-registered 503B outsourcing facility based in Largo, Florida. A wholly owned subsidiary of Belcher Pharmaceuticals, the company focuses on the development and production of high-quality sterile injectable medications to address nationwide drug shortages and unmet clinical needs.
The company utilizes advanced, humanless robotic manufacturing technology within ISO-grade isolated suites to ensure cGMP compliance and product sterility. Their operations include in-house analytical and microbiological testing, supporting a portfolio that serves hospitals, clinics, and pharmacies across the United States.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Sterile Injectables / 503B Outsourcing
SIZE & FINANCIALS
Employees:51-200
Founded:2017
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Belcher Pharmaceuticals, LLC
Acquired By:Belcher Pharmaceuticals, LLC
Key Partnerships:Glenmark Pharmaceuticals (Reference-listed drug provider for generic Epinephrine injection)
COMPETITION
Position:Niche Player
Competitors:Sagent Pharmaceuticals, Thermo Fisher Scientific
LEADERSHIP
Key Executives:
Mike Gebs - President
LINKS
Website:bpi-labs.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BPI Labs, LLC. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.